NCT07162558

Brief Summary

This randomized clinical trial aimed to evaluate the effectiveness of a child-centered empowerment model in improving the lifestyle of children with leukemia. The study focused on whether structured empowerment interventions could significantly enhance daily habits and overall well-being in pediatric oncology patients. The main research questions were: Does the child-centered empowerment model improve the lifestyle of children with leukemia? Can this complementary and non-invasive method be considered a viable approach for supporting pediatric care? Participants (N = 46) aged 7-13 years were randomly assigned to either the intervention group, which received empowerment training in four dimensions (perceived threat, self-efficacy, educational participation, and evaluation), or the control group, which received routine care. Pre- and post-intervention assessments were conducted using a validated lifestyle questionnaire measuring nutrition, sleep, physical activity, physical health, and stress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2024

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 31, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 9, 2025

Completed
Last Updated

September 9, 2025

Status Verified

August 1, 2025

Enrollment Period

8 days

First QC Date

August 31, 2025

Last Update Submit

August 31, 2025

Conditions

Keywords

Empowerment ModelQuality of LifePediatric NursingChildren

Outcome Measures

Primary Outcomes (1)

  • Lifestyle Scores

    The primary outcome measure evaluates changes in the lifestyle of children with leukemia. Lifestyle is assessed using a validated lifestyle questionnaire covering five domains: nutrition, sleep, physical activity, physical health, and stress. The tool includes 38 items rated on a 4-point Likert scale ("often" to "never"), with higher scores indicating a more favorable lifestyle.

    Lifestyle scores are measured at two time points - baseline (before the intervention) and one month after completion of the empowerment program

Study Arms (2)

Child-Centered Empowerment

EXPERIMENTAL

Behavioral: Child-Centered Empowerment Intervention Participants in this group receive the child-centered empowerment program, a structured behavioral intervention designed to enhance coping skills, promote self-efficacy, and improve lifestyle in children with leukemia. The program is based on four dimensions of empowerment: Perceived Threat: Increasing awareness of illness, its complications, and the treatment process through group discussions. Self-Efficacy: Practicing problem-solving and self-management techniques to strengthen self-belief, self-control, and confidence in handling illness-related challenges. Educational Participation: Children receive educational cards at the end of each session and are encouraged to share the learned content with family members to reinforce responsibility and engagement. Evaluation: Continuous follow-up and assessment of learning after each session to ensure understanding and active participation.

Behavioral: Child-Centered Empowerment Intervention

Routine Care

NO INTERVENTION

Participants in this group continue with their usual oncology care and do not receive any additional empowerment training. Routine medical and nursing care is delivered according to standard clinical practice without structured behavioral interventions

Interventions

Participants in this group receive the child-centered empowerment program, a structured behavioral intervention designed to enhance coping skills, promote self-efficacy, and improve lifestyle in children with leukemia. The program is based on four dimensions of empowerment: Perceived Threat: Increasing awareness of illness, its complications, and the treatment process through group discussions. Self-Efficacy: Practicing problem-solving and self-management techniques to strengthen self-belief, self-control, and confidence in handling illness-related challenges. Educational Participation: Children receive educational cards at the end of each session and are encouraged to share the learned content with family members to reinforce responsibility and engagement. Evaluation: Continuous follow-up and assessment of learning after each session to ensure understanding and active participation.

Child-Centered Empowerment

Eligibility Criteria

Age7 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 7-13 years diagnosed with leukemia and admitted to the pediatric oncology clinic.
  • Children and parents willing to participate in the study and provide written informed consent (parents) and assent (children).
  • No reported history of specific mental disorders as declared by parents.

You may not qualify if:

  • Inconsistent participation in empowerment sessions (e.g., missing scheduled intervention sessions).
  • Withdrawal from the study by the child or family at any time. Any condition preventing the child from completing questionnaires or participating in group discussions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Near East University

Nicosia, KKTC (Turkish Republic of Northern Cyprus), 99138, Cyprus

Location

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Condition Hierarchy (Ancestors)

Leukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Pouran Varvani Farahani, PhD

    Study Principal Investigator PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double-Blind (Investigator, Outcomes Assessor): To minimize bias, a double-blind approach was employed. The researcher responsible for data collection was unaware of the group assignments, and the statistician analyzing the results was also blinded to the allocation. The data were processed under masked labels (x1 and x2) to preserve objectivity.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants in this clinical trial were randomly assigned to one of two groups: an experimental group receiving the child-centered empowerment intervention and a control group receiving routine pediatric oncology care. Both groups were followed in parallel throughout the study duration.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University,

Study Record Dates

First Submitted

August 31, 2025

First Posted

September 9, 2025

Study Start

September 2, 2024

Primary Completion

September 10, 2024

Study Completion

December 30, 2024

Last Updated

September 9, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

There is no plan to make IPD available to other researchers

Locations